Harnessing immunotherapy to combat COVID-19: A modern snake oil or silver bullet?

Coronavirus disease 2019 (COVID-19), an infectious disease caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), has emerged into a global health and economic menace. Amidst the COVID-19 turmoil, recent failures/uncertain outcomes in clinical trials involving the anti-malarial (hydro...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunjegaonkar, Shivshankar Malkarjun, Shanmugarajan, Thukani Sathanantham, Arunsundar, Mohanasundaram, Arjun, Uppuluri Varuna Naga Venkata, Devi, Kadirrel, Wankhede, Sagar Baliram, Ravichandiran, Velayutham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2021
Materias:
Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603945/
https://www.ncbi.nlm.nih.gov/pubmed/34238584
http://dx.doi.org/10.1016/j.therap.2020.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603945/
https://www.ncbi.nlm.nih.gov/pubmed/34238584
http://dx.doi.org/10.1016/j.therap.2020.10.004

Ejemplares similares